The invention provides a pharmaceutical unit dosage form comprising 4-phenylbutyric acid (4-PB) as a free acid or as a salt as a prodrug, a codrug, a co-crystal or any salt or hydrate or solvate thereof. The invention further provides the use of said pharmaceutical dosage form for the prevention or treatment of cancer and methods for preparing said pharmaceutical dosage form.